Journal of Psychopharmacology Lifetime Classic Psychedelic Use and Headaches: A Cross-Sectional Study A cross-sectional study finds that lifetime psychedelic use is linked to a lower prevalence of frequent severe headaches, suggesting therapeutic potential.
Journal of Mental Health and Substance Research Psychedelic Pharmacology in Psychiatry: The Mechanisms and Therapeutic Potential of Psilocybin, MDMA, and LSD in Mental Health Disorders This review examines the mechanisms and therapeutic potential of psilocybin, MDMA, and LSD for depression, PTSD, and anxiety disorders.
Pharmaceuticals Extraction Yields of Psilocybin and Psilocin: A Short Review of Current Methods and Their Implications A systematic review of psilocybin and psilocin extraction methods, highlighting the most effective techniques for maximizing yield and purity
BMC Medical Education Further Education in Psychedelic-Assisted Therapy – Experiences from Switzerland Examining Switzerland’s training framework for psychedelic-assisted therapy and its role in ensuring safe and effective clinical implementation.
The Arts in Psychotherapy ‘Go with the "wave of music" to dive deep’: Exploring perceptions of psychedelic-assisted therapy and the role of music within this practice This study explores how music shapes psychedelic-assisted therapy, serving as both a guide and container for emotional experiences.
ACS Pharmacology & Translational Science Psychedelics and Eating Disorders: Exploring the Therapeutic Potential for Anorexia Nervosa and Beyond A review of the therapeutic potential of psychedelics for anorexia nervosa, highlighting neurobiological and psychological mechanisms.
Neuropharmacology Side Effects of Microdosing Lysergic Acid Diethylamide and Psilocybin: A Systematic Review of Potential Physiological and Psychiatric Outcomes A systematic review on the physiological and psychiatric side effects of microdosing LSD and psilocybin, including anxiety, BP increase, and cognitive impairment.
The American Journal of Psychiatry Irremediable Psychiatric Suffering, a Potential Indication for Psilocybin Treatment Exploring psilocybin’s potential as a treatment for patients with irremediable psychiatric suffering who may otherwise seek euthanasia.
Neuroscience Applied A Review of Psychedelics Trials Completed in Depression, Informed by European Regulatory Perspectives A systematic review of completed psychedelics trials for depression, highlighting key findings and regulatory challenges.
PSM Biological Research The Role of Psychedelics in Treating Mental Health Disorders: A Mini-Review A review of historical and contemporary research on psychedelics in treating depression, PTSD, and anxiety, highlighting their therapeutic potential.
The Permanente Journal A Review of the Federal Drug Administration Pipeline and Proposed California Legislation on Medicinal Psychedelics A review of FDA psychedelic trials and California’s legislative efforts to expand access, balancing safety, efficacy, and regulatory concerns.
Journal of Clinical Medicine Psychedelics and Suicide-Related Outcomes: A Systematic Review A systematic review evaluating the effects of psychedelics on suicide-related outcomes, highlighting potential benefits and risks of psilocybin, MDMA, and LSD.
General Psychiatry Expanded Access to Psychedelic Treatments: Comparing American and Canadian Policies A policy analysis comparing Canada’s Special Access Program and the U.S. FDA’s Expanded Access Program for psychedelic-assisted therapy.
Book Review Book Review: Mushroom Pharmacy: A Practical Guide to Psychedelic Mushrooms Mushroom Pharmacy: A Practical Guide to Psychedelic Mushrooms, science-backed guide by Dr. Stacey Simmons explores the neuroscience, therapeutic benefits, and safe use of psychedelic mushrooms.
University of Lethbridge Canadian Psychologists’ and Psychology Graduate Students’ Perceptions of Psychedelic Therapy A study examining Canadian psychologists’ and psychology graduate students’ perceptions of psychedelic therapy, highlighting knowledge gaps and training needs.
Journal of Neurochemistry Serotonergic Psychedelics Rapidly Modulate Evoked Glutamate Release in Cultured Cortical Neurons A study on how psychedelics modulate glutamate release in cortical neurons, highlighting their potential for treating depression and enhancing neuroplasticity.
New Mexico New Mexico SB0219 - Medical Psilocybin Act New Mexico’s SB0219 proposes a regulated medical psilocybin program, establishing legal pathways for therapeutic use while ensuring oversight and research funding.
Rhode Island Rhode Island H5186 - Uniform Controlled Substances Act Amendment Rhode Island’s proposed bill H5186 would allow personal cultivation of psilocybin and create a pathway for regulated medical use pending federal changes.
Current Opinion in Psychology Psychedelics and connectedness to natural and social worlds: An examination of the evidence and a proposed conceptual framework Psychedelics enhance connection to nature and social bonds through ego dissolution and emotional processing, offering insights for therapy and sustainability.
New Hampshire New Hampshire HB528 - Legalization of Psilocybin for Adults 21+ HB528 proposes legalizing psilocybin for adults 21+ in New Hampshire, removing criminal penalties while maintaining age restrictions.
Cancer Medicine Psychedelics for Cancer Pain and Associated Psychological Distress: A Narrative Review of a Potential Strategy A review of psychedelics for cancer pain and distress, highlighting their potential role in reducing pain perception and improving mood.
Depression Psilocybin Therapy for Clinicians With Symptoms of Depression From Frontline Care During the COVID-19 Pandemic This study aimed to evaluate the efficacy of psilocybin therapy in reducing symptoms of depression, burnout, and PTSD in frontline clinicians affected by the COVID-19 pandemic.
Premier Journal of Science Psilocybin Microdosing for Anxiety Relief in Young Adults: A Comparative Review of Emerging Evidence A systematic review analyzing the potential benefits of psilocybin microdosing for anxiety relief, emotional resilience, and neuroplasticity.
Psilocybin Into the Wild Frontier: Mapping the Terrain of Adverse Events in Psychedelic-Assisted Therapies This study aims to explore the risks associated with psychedelic-assisted therapies (PATs) by evaluating potential adverse events (AEs) to develop a comprehensive and standardized assessment framework.
Psilocybin The mushroom was more alive and vibrant: Patient reports of synthetic versus organic forms of psilocybin This study aimed to explore the differences in patient-reported experiences when using synthetic psilocybin, whole Psilocybe cubensis mushrooms, and a mycological extract in a therapeutic context.
